SYSTEMIC PROTEOMIC PROFILES OF COPD PATIENTS AT CLINICAL STABILITY AND EXACERBATION

被引：0
|
作者：
Enriquez-Rodriguez, C. J. [1 ]
Casadevall, C. [1 ]
Pascual-Guardia, S. [1 ]
Faner, R. [2 ]
Peces-Barba, G. [3 ]
Lopez-Campos, J. L. [4 ]
Monso, E. [5 ]
Agusti, A. [6 ]
Gea Guiral, J. [7 ]
机构：
[1] UPF, Hosp del Mar IMIM, Dept MELIS, CIBERES,ISCiii, Barcelona, Spain
[2] UB, Hosp Clin, FCRB, CIBERES,ISCiii, Barcelona, Spain
[3] UAB, ISCiiiParc Tauli, Fdn Jimenez Diaz Quiron, CIBERES, Madrid, Spain
[4] US, Hosp Virgen del Rocio, CIBERES, ISCiii, Seville, Spain
[5] UAB, Consorci Hosp Parc Tauli, CIBERES, ISCiii, Barcelona, Spain
[6] UAB, Consorci Hosp Parc Tauli, CIBERES, Barcelona, Spain
[7] Hosp del Mar IMIM, Dept MELIS, CIBERES, ISCiii, Barcelona, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.3871
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3871
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Systemic steroids in acute exacerbation of COPD - from guidelines to bedside
    Wang, P. -H.
    Cheng, S. -L.
    Wang, H. -C.
    Chang, H. -T.
    Hsu, Y. -L.
    Chen, Y. -S.
    Chang, C. -Y.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (11) : 705 - 708
  • [42] Should systemic steroids be prescribed for acute exacerbation of COPD, or not? Response
    不详
    REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (01) : 162 - 164
  • [43] EVALUATION OF THE IMMUNOGLOBULIN G AND SUBCLASSES IN COPD EXACERBATOR PHENOTYPE IN 2 TIMES: EXACERBATION AND CLINICAL STABILITY
    Juanola Pla, J.
    Boixeda Viu, R.
    Moreno Hernandez, M. I.
    Bartolome Regue, M.
    De La Torre Terron, M. D. C.
    Garcia Caballero, M.
    Serrano Fores, A.
    Pola Pena, M.
    Palomera Fanegas, E.
    Serra Prat, M.
    Almirall Pujol, J.
    CHEST, 2020, 157 (06) : 280A - 280A
  • [44] Dissociation Between Airway And Systemic Inflammatory Changes At Exacerbation In COPD
    Donaldson, G. C.
    Belchamber, K. B. R.
    Singh, R.
    Kolsum, U.
    Barker, B.
    Brightling, C. E.
    Singh, D.
    Barnes, P. J.
    Donnelly, L.
    Wedzicha, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [45] Efficacy and Safety of Different Doses of Systemic Corticosteroids in COPD Exacerbation
    Pu, Xiaofeng
    Liu, Liang
    Feng, Bimin
    Wang, Maolin
    Dong, Limei
    Zhang, Zhengji
    Fan, Qingze
    Li, Ying
    Wang, Guojun
    RESPIRATORY CARE, 2021, 66 (02) : 316 - 326
  • [46] Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study
    Suzuki, Masaru
    Makita, Hironi
    Ito, Yoichi M.
    Nagai, Katsura
    Konno, Satoshi
    Nishimura, Masaharu
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (05) : 1289 - 1297
  • [47] Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
    Beghe, Bianca
    Verduri, Alessia
    Roca, Mihai
    Fabbri, Leonardo M.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (04) : 993 - 995
  • [48] Examination of COPD management in patients hospitalized with an acute exacerbation of COPD
    Wirth, Ingrid M.
    Penz, Erika D.
    Marciniuk, Darcy D.
    CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2022, 6 (01) : 14 - 23
  • [49] β-Blockers and Risk of COPD Exacerbation Requiring Hospitalisation in Patients with COPD
    Afonso, Ana
    Verhamme, Katia M. C.
    Brusselle, Guy G. O.
    Sturkenboom, Miriam C. J. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S65 - S66
  • [50] PROTEOMIC ANALYSIS OF SPUTUM IN PATIENTS WITH COPD AND COPD EXACERBATIONS
    Uh, Soo-Taek
    Kim, Yang Ki
    Kim, Ki Up
    Park, Sung Woo
    Kim, Do Jin
    Jang, An Soo
    Park, Choon Sik
    Kim, Yong Hoon
    RESPIROLOGY, 2010, 15 : 96 - 96
12345